Iconic Therapeutics' Series B Round

Iconic Therapeutics raised a round of funding on May 16, 2007.

Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating an understanding of the role of Tissue Factor biology to new therapeutics for retinal disease and cancer. The…

Articles about Iconic Therapeutics' Series B Round: